. Good or best practice statements: proposal for the
operationalisation and implementation of GRADE guidance. BMJ
Evid Based Med 2023;28:189-96.
16. Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, et al.
ESVM Guideline on peripheral arterial disease. Vasa 2019;48:1-79.
17. Aboyans V, Ricco JB, Bartelink ML, Björck M, Brodmann M, Cohner T,
et al. [2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)]. Kardiol Polska 2017;75:1065-160.

18. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V,
et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur
Heart J 2020;41:255-323.
19. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L,
et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modiﬁcation to reduce cardiovascular risk. Eur Heart J
2020;41:111-88.
20. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al.
Global Vascular Guidelines on the Management of Chronic LimbThreatening Ischemia. Eur J Vasc Endovasc Surg 2019;58:S1-109.e33.
21. 10. Cardiovascular Disease and Risk Management: Standards
of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):
S144-74.
22. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.
Diabetes Care 202